Pfizer Applies for COVID-19 Vaccine EUA
Today, Pfizer and BioNTech submitted an emergency use authorization (EUA) request to the U.S. Food and Drug Administration (FDA) for its mRNA vaccine candidate for use against the COVID-19 virus. According to Pfizer, today’s FDA filing would potentially enable use of the vaccine in high-risk populations in the U.S. by the middle to end of…
Read More »